Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 90 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1227. Clear
Clear
Q2
BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. for BLUE CROSS AND BLUE SHIELD OF FLORIDA INC
2nd Quarter (Apr 1 - June 30) 2026 · Florida · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View → Q2
STANTON PARK GROUP for VERTEX PHARMACEUTICALS INCORPORATED
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $50,000.00 income
Health Issues
View → Q2
AVENUE SOLUTIONS for VERTEX PHARMACEUTICALS INCORPORATED
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View → Q2
AMERICAN ASSOCIATION OF NURSE PRACTITIONERS for AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate
Health Issues, Budget/Appropriations, Government Issues, Medicare/Medicaid
View → Q2
BLUE CROSS AND BLUE SHIELD ASSOCIATION for BLUE CROSS AND BLUE SHIELD ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Pharmacy, Health Issues, Medicare/Medicaid
View → Q2
GUIDEWELL MUTUAL HOLDING CORPORATION for GUIDEWELL MUTUAL HOLDING CORPORATION
2nd Quarter (Apr 1 - June 30) 2026 · Florida · House · Senate
Medicare/Medicaid, Pharmacy
View → Q2
AMERICAN PSYCHIATRIC ASSOCIATION for AMERICAN PSYCHIATRIC ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Medical/Disease Research/Clinical Labs, Budget/Appropriations, Health Issues, Veterans
View → Q2
CGCN GROUP, LLC for VERTEX PHARMACEUTICALS INCORPORATED
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View → Q2
TIBER CREEK GROUP for VERTEX PHARMACEUTICALS
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $60,000.00 income
Health Issues, Defense
View → Q2
CROSSROADS STRATEGIES, LLC for VERTEX PHARMACEUTICALS INCORPORATED
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $50,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Trade (domestic/foreign)
View → Q2
AMERICAN SOCIETY OF ANESTHESIOLOGISTS for AMERICAN SOCIETY OF ANESTHESIOLOGISTS
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Veterans
View → Q2
PRIME THERAPEUTICS for PRIME THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2026 · Minnesota · House · Senate
Health Issues, Medicare/Medicaid
View → Q2
EMPIRE CONSULTING GROUP for VERTEX PHARMACEUTICALS INCORPORATED
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income
Health Issues
View → Q2
VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Budget/Appropriations
View → Q2
BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. for BLUE CROSS AND BLUE SHIELD OF KANSAS INC
2nd Quarter (Apr 1 - June 30) 2026 · Kansas · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View → Q2
MARSHALL & POPP, LLC for VERTEX PHARMACEUTICALS INCORPORATED
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid, Trade (domestic/foreign)
View → Q2
AEGIS LLC for TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRIS
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $50,000.00 income
Pharmacy
View → Q1
CGCN GROUP, LLC for VERTEX PHARMACEUTICALS INCORPORATED
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $80,000.00 income
Health Issues, Medicare/Medicaid
View → Q1
AVENUE SOLUTIONS for VERTEX PHARMACEUTICALS INCORPORATED
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View → Q1
GUIDEWELL MUTUAL HOLDING CORPORATION for GUIDEWELL MUTUAL HOLDING CORPORATION
1st Quarter (Jan 1 - Mar 31) 2026 · Florida · House · Senate
Medicare/Medicaid, Pharmacy
View → Q1
BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. for BLUE CROSS AND BLUE SHIELD OF FLORIDA INC
1st Quarter (Jan 1 - Mar 31) 2026 · Florida · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View → Q1
PRIME THERAPEUTICS for PRIME THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · Minnesota · House · Senate
Health Issues, Medicare/Medicaid
View → Q1
STANTON PARK GROUP for VERTEX PHARMACEUTICALS INCORPORATED
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $50,000.00 income
Health Issues
View → Q1
AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS for AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate
Insurance, Education, Medicare/Medicaid, Health Issues
View → Q1
BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. for BLUE CROSS AND BLUE SHIELD OF KANSAS INC
1st Quarter (Jan 1 - Mar 31) 2026 · Kansas · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View →
Page 1 of 4 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem